VivoSim Labs, Inc. Additional Paid in Capital, Common Stock
VivoSim Labs, Inc. (VIVS) had Additional Paid in Capital, Common Stock of $354.99 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital, Common Stock $354.99M.
- 2026-03-31: Additional Paid in Capital, Common Stock $354.90M.
- 2025-12-31: Additional Paid in Capital, Common Stock $354.67M.
- 2025-09-30: Additional Paid in Capital, Common Stock $354.61M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $354.99M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $354.90M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $354.67M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $354.61M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $354.54M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $352.65M 10-K · filed 2026-07-14 | |
| 2024-12-31 | $349.36M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $349.23M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $349.66M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $343.27M 10-K · filed 2025-06-05 | $343.26M 10-K · filed 2024-05-31 |
| 2023-12-31 | $342.80M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $341.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $340.79M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $340.32M 10-K · filed 2024-05-31 | |
| 2022-12-31 | $339.82M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $339.27M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $338.60M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $337.94M 10-K · filed 2023-07-14 | |
| 2021-12-31 | $337.11M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $336.53M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $336.14M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $335.48M 10-K · filed 2022-06-10 | |
| 2020-12-31 | $314.44M 10-Q · filed 2021-02-08 | |
| 2020-09-30 | $311.16M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $306.89M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $306.09M 10-K · filed 2021-06-15 | $305.96M 10-K · filed 2020-05-28 |
| 2019-12-31 | $305.57M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $304.31M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $303.09M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $296.93M 10-K · filed 2020-05-28 | |
| 2018-12-31 | $289.33M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $286.13M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $282.78M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $278.60M 10-K · filed 2019-06-03 | |
| 2017-12-31 | $275.18M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $270.84M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $266.59M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $261.59M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $259.47M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $231.48M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $224.39M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $222.96M 10-K · filed 2017-06-07 | |
| 2015-12-31 | $221.44M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $218.10M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $216.01M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $170.91M 10-K · filed 2016-06-09 | |
| 2014-12-31 | $162.73M 10-Q · filed 2015-02-06 | |
| 2014-03-31 | $140.42M 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |